Literature DB >> 9521265

Double pathology in Rasmussen's syndrome: a window on the etiology?

Y M Hart1, F Andermann, Y Robitaille, K D Laxer, T Rasmussen, R Davis.   

Abstract

The syndrome of chronic encephalitis with epilepsy (Rasmussen's syndrome) typically occurs in children and is characterized by the development of intractable focal seizures, progressive hemiparesis and intellectual deterioration. The etiology is unknown, and the pathological abnormalities vary from those of active disease, with numerous microglial nodules, with or without neuronophagia, perivascular round cells and glial scarring, to those of remote disease, demonstrated by neuronal loss, gliosis and perivascular round cells but few microglial nodules. We describe five patients presenting with clinical features typical of Rasmussen's syndrome, in whom pathological examination showed a second, previously unsuspected pathology in addition to the changes of chronic encephalitis. Two of the patients had vascular abnormalities bearing some resemblance to cavernous angiomata, one had a tumor, one had tuberous sclerosis, and one the forme fruste of tuberous sclerosis. The coexistence of a second pathology in these patients may provide information about the underlying mechanism of this rare condition.

Entities:  

Mesh:

Year:  1998        PMID: 9521265     DOI: 10.1212/wnl.50.3.731

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

Review 1.  Post infectious CNS disorders: towards a unified approach.

Authors:  Marc Gotkine; Peter G E Kennedy; Israel Steiner
Journal:  J Neurol       Date:  2010-09-21       Impact factor: 4.849

Review 2.  Inflammatory pathways of seizure disorders.

Authors:  Nicola Marchi; Tiziana Granata; Damir Janigro
Journal:  Trends Neurosci       Date:  2013-12-16       Impact factor: 13.837

Review 3.  Rasmussen encephalitis with dual pathology in a patient without seizures: case report and literature review.

Authors:  Vijay M Ravindra; Marcus D Mazur; Carrie A Mohila; Matthew T Sweney; Aimee Hersh; Robert J Bollo
Journal:  Childs Nerv Syst       Date:  2015-06-02       Impact factor: 1.475

Review 4.  Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).

Authors:  Carlos A Pardo; Rima Nabbout; Aristea S Galanopoulou
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 5.  [Recent insights into Rasmussen encephalitis].

Authors:  C G Bien; C E Elger
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

Review 6.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

Review 7.  Development of anaplastic ependymoma in Rasmussen's encephalitis: review of the literature and case report.

Authors:  Raj Kumar; Abrar Ahad Wani; Jaypal Reddy; Lily Pal; Sunil Pradhan
Journal:  Childs Nerv Syst       Date:  2005-06-01       Impact factor: 1.475

8.  Difficulties in differentiation of Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen syndrome.

Authors:  Justyna Paprocka; Ewa Jamroz; Dariusz Adamek; Elzbieta Marszal; Marek Mandera
Journal:  Childs Nerv Syst       Date:  2005-10-25       Impact factor: 1.475

Review 9.  Classification and pathological characteristics of the cortical dysplasias.

Authors:  Richard A Prayson
Journal:  Childs Nerv Syst       Date:  2014-10-09       Impact factor: 1.475

10.  Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex.

Authors:  Martin Wirenfeldt; Ryan Clare; Spencer Tung; Alexander Bottini; Gary W Mathern; Harry V Vinters
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.